Comparing Real-World Effectiveness of Dulaglutide and Insulin as the First Injectable for Patients with Type 2 Diabetes: An Australian Single-Site Retrospective Chart Review

被引：0
|
作者：
Jared A. Houssarini
Alan J. M. Brnabic
Marwan Obaid
机构：
[1] The University of Notre Dame Australia,School of Medicine Sydney
[2] Eli Lilly,Faculty of Medicine
[3] University of New South Wales,Diabetes Centre
[4] Bankstown-Lidcombe Hospital,undefined
[5] Innerwest Specialist Centre,undefined
来源：
Diabetes Therapy | 2022年 / 13卷
关键词：
Real-world setting; HbA1c; Dulaglutide; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：131 / 144
页数：13
相关论文
共 50 条
  • [1] Comparing Real-World Effectiveness of Dulaglutide and Insulin as the First Injectable for Patients with Type 2 Diabetes: An Australian Single-Site Retrospective Chart Review
    Houssarini, Jared A.
    Brnabic, Alan J. M.
    Obaid, Marwan
    DIABETES THERAPY, 2022, 13 (01) : 131 - 144
  • [2] Real-World Effectiveness of Dulaglutide in Patients with Type 2 Diabetes Mellitus: A Literature Review
    Susan Robinson
    Kristina S. Boye
    Reema Mody
    Alena Antonie Strizek
    Manige Konig
    Raleigh E. Malik
    Tessa Kennedy-Martin
    Diabetes Therapy, 2020, 11 : 1437 - 1466
  • [3] Real-World Effectiveness of Dulaglutide in Patients with Type 2 Diabetes Mellitus: A Literature Review
    Robinson, Susan
    Boye, Kristina S.
    Mody, Reema
    Strizek, Alena Antonie
    Konig, Manige
    Malik, Raleigh E.
    Kennedy-Martin, Tessa
    DIABETES THERAPY, 2020, 11 (07) : 1437 - 1466
  • [4] Real-world effectiveness of liraglutide versus dulaglutide in Japanese patients with type 2 diabetes: a retrospective study
    Kenichi Tanaka
    Yosuke Okada
    Akemi Tokutsu
    Yoshiya Tanaka
    Scientific Reports, 12
  • [5] Real-world effectiveness of liraglutide versus dulaglutide in Japanese patients with type 2 diabetes: a retrospective study
    Tanaka, Kenichi
    Okada, Yosuke
    Tokutsu, Akemi
    Tanaka, Yoshiya
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [6] REAL WORLD EFFECTIVENESS OF DULAGLUTIDE AMONG PATIENTS WITH TYPE 2 DIABETES
    Mody, R.
    Yu, M.
    Fernandez, L.
    Shui, A.
    Kallenbach, L.
    Slipski, L.
    de Oliveira, Piras C.
    VALUE IN HEALTH, 2017, 20 (05) : A164 - A164
  • [7] Switching from insulin to dulaglutide therapy in patients with type 2 diabetes: A real-world data study
    Lee, Jiwoo
    Kim, Hwi Seung
    Jung, Chang Hee
    Park, Joong-Yeol
    Lee, Woo Je
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2021, 37 (08)
  • [8] Long-Acting Insulin Analogs: A Review of "Real-World" Effectiveness in Patients with Type 2 Diabetes
    Pollock, Richard F.
    Erny-Albrecht, Katrina M.
    Kalsekar, Anupama
    Bruhn, David
    Valentine, William J.
    CURRENT DIABETES REVIEWS, 2011, 7 (01) : 61 - 74
  • [9] Real-world effectiveness, adherence and persistence among patients with type 2 diabetes mellitus initiating dulaglutide treatment
    Mody, Reema
    Grabner, Michael
    Yu, Maria
    Turner, Ralph
    Kwan, Anita Y. M.
    York, Whitney
    Lando, Laura Fernandez
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (06) : 995 - 1003
  • [10] Clinical effectiveness of combination therapy with dulaglutide, SGLT2 inhibitor and metformin with or without insulin in Indian adults with type 2 diabetes: a real-world retrospective study
    Bhattacharyya, Supratik
    CLINICAL DIABETOLOGY, 2020, 9 (04): : 233 - 238
12345